Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). J of Skin [Internet]. 2020 Sep. 2 [cited 2025 Apr. 19];4(5):s44. Available from: https://skin.dermsquared.com/skin/article/view/993